How to Make Semax/Selank Nasal Spray: Safety Checklist

A recent Reddit question asked for instructions to reconstitute a 10 mg/10 mg Semax/Selank combo vial into a nasal spray and how the math changes when two peptides are in the same vial. That is a real planning problem, but the safe public answer is not a recipe. It is a checklist for what must be known before someone relies on any calculation.

The key details are product identity, whether the product is meant for this route, what liquid is supposed to be used, final volume, concentration per spray, sterility and beyond-use date, schedule, and symptoms or outcomes worth tracking. If any of those are unclear, pause and ask the prescriber, pharmacist, or manufacturer.

Keep the two ingredients distinct in your source notes. Review the Semax reference profile and Selank reference profile before recording a combined product, and preserve the exact label wording.

If you are still sorting out diluent language, read the BAC water and reconstitution checklist. If your question is about timing multiple sprays rather than preparing the product, the protocol guide covers the reminder and logging workflow without substituting for prescriber instructions.

1. 1. Exact product and route

   Record the label name, whether it is Semax, Selank, or a combo product, the amount of each peptide, lot or batch details, and whether the label or prescriber specifically supports nasal use.

2. 2. Instructions and diluent

   Save the written instructions for what liquid to use, how much to add, storage after mixing, and discard timing. Do not substitute a forum answer for missing sterile-preparation instructions.

3. 3. Final volume and concentration

   Write down the final liquid volume and the amount of each peptide per milliliter. Combo vials require separate tracking for each ingredient because one spray may contain both.

4. 4. Device output

   If a metered spray device is involved, verify the device's stated spray volume from its labeling or supplier documentation. Do not assume every pump dispenses the same amount.

5. 5. Professional questions

   Keep a short list for a pharmacist or clinician: route, sterility, compounding, storage, beyond-use date, dose, missed sprays, and what changes if side effects or nasal irritation occur.

CDC injection-safety guidance treats aseptic preparation, vial handling, sterility, and stability as patient-safety issues, not optional details. FDA guidance on compounding also warns that poor compounding practices can create contamination or incorrect active ingredient amounts. A consumer app should not replace that professional boundary.

The Peptide App is useful once the professional instructions are clear: save the record, connect it to a protocol, log each use, set reminders, and keep symptom or outcome notes. It is not a sterile compounding guide, a product validator, or a dose recommender.

For a broader framework, read the peptide protocol tracking guide. The same habit applies here: keep the decision source separate from the tracking system that records what happened.

If the preparation details are already verified and the open question is timing, use the separate intranasal peptide spray scheduling checklist to organize written instructions without inventing an interval.

Create the protocol before the first planned use. Add the compound name, route, source of instructions, preparation date, storage location, planned schedule, and the concentration fields you have verified. If the math changes because the final volume changes, create a new record rather than editing away the old one.

When the protocol starts, log each spray or dose event with the time, amount, and notes. If you notice nasal irritation, headaches, sleep changes, appetite changes, or anything else you planned to monitor, record it as an observation and bring the pattern back to the clinician instead of tuning the protocol from a comment thread.